Characteristics and Outcomes of Younger Adult Patients (Pts) with Myelodysplastic Syndromes (MDS): A Multicenter Retrospective Study

被引：0
|
作者：
Abaza, Yasmin [1 ]
Xie, Zhuoer [2 ]
Burkart, Madelyn [1 ]
Badar, Talha [3 ]
Desai, Pinkal [4 ]
Shallis, Rory M. [5 ,6 ]
Patel, Anand Ashwin [7 ]
Cohen-Nowak, Adam [1 ]
Oh, Timothy S. [1 ]
Walker, Chelsea [8 ]
Easwar, Neela [4 ]
Kewan, Tariq [5 ,6 ]
Cannova, Joseph [7 ]
Bell-Burdett, Kirsten [1 ]
Al Ali, Najla H. [2 ]
Sallman, David A. [9 ]
Roboz, Gail J. [4 ]
Carraway, Hetty E. [10 ]
Zeidan, Amer M. [5 ,6 ]
Patnaik, Mrinal M. [11 ]
Altman, Jessica K. [1 ]
Komrokji, Rami S. [2 ]
机构：
[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[3] Mayo Clin, Jacksonville, FL USA
[4] New York Presbyterian Hosp, Weill Cornell Med, New York, NY USA
[5] Yale Sch Med, Sect Hematol, Dept Internal Med, Killingworth, CT USA
[6] Yale Canc Ctr, Killingworth, CT USA
[7] Univ Chicago, Sect Hematol Oncol, Dept Med, Chicago, IL USA
[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[9] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[10] Cleveland Clin, Leukemia Program, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH USA
[11] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188328
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页数：6
相关论文
共 50 条
  • [1] Myelodysplastic syndromes (MDS) in childhood: A retrospective study in Japan
    Sasaki, H
    Manabe, A
    Kojima, S
    Tsuchida, M
    Hayashi, Y
    Ikuta, K
    Okamura, J
    Koike, K
    Ohara, A
    Ishii, E
    Komada, Y
    Hibi, S
    Nakahata, T
    LEUKEMIA, 2000, 14 (05) : 968 - 968
  • [2] Impact of Type of Hypomethylating Agent (HMA) Used on Outcomes of Patients (Pts) with Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) - a Large, Multicenter, Retrospective Analysis
    Bewersdorf, Philipp
    Kewan, Tariq
    Blaha, Ondrej
    Stahl, Maximilian
    Al Ali, Najla H.
    DeZern, Amy E.
    Sekeres, Mikkael A.
    Uy, Geoffrey L.
    Carraway, Hetty E.
    Desai, Pinkal
    Griffiths, Elizabeth A.
    Stein, Eytan M.
    Brunner, Andrew M.
    McMahon, Christine M.
    Zeidner, Joshua F.
    Savona, Michael R.
    Stempel, Jessica M.
    Chandhok, Namrata Sonia
    Ramaswamy, Rahul
    Roboz, Gail J.
    Rolles, Benjamin
    Wang, Eunice S.
    Harris, Amyah C.
    Amaya, Maria L.
    Hawkins, Hayley
    Grenet, Justin
    Gurnari, Carmelo
    Shallis, Rory M.
    Xie, Zhuoer
    Maciejewski, Jaroslaw P.
    Sallman, David A.
    Della Porta, Matteo Giovanni
    Komrokji, Rami S.
    Zeidan, Amer M.
    BLOOD, 2023, 142
  • [3] Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS)
    Al-Issa, Karam
    Madanat, Yazan F.
    Mukherjee, Sudipto
    Hirsch, Cassandra M.
    Gerds, Aaron T.
    Abuhadra, Nour
    Makhoul, Ahed
    Awada, Hassan
    Asad, Mohammad Fahad B.
    Goyal, Abhinav
    Advani, Anjali S.
    Kuzmanovic, Teodora
    Przychodzen, Bartlomiej P.
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    Nazha, Aziz
    BLOOD, 2017, 130
  • [4] Characteristics and Outcome Of Myelodysplastic Syndromes (MDS) Patients With Autoimmune Diseases
    Komrokji, Rami S.
    Kulasekararaj, Austin G.
    Al Ali, Najla H.
    Kordasti, Shahram Y.
    Bart-smith, Emily
    Benjamin, Craig
    Padron, Eric
    Zhang, Ling
    Lancet, Jeffrey E.
    List, Alan
    Mufti, Ghulam J.
    Epling-Burnette, Pearlie K.
    BLOOD, 2013, 122 (21)
  • [5] A Phase II Study Of The Combination Of Azacitidine and Lenalidomide In Patients (pts) With Higher Risk Myelodysplastic Syndromes (MDS)
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    Daver, Naval
    Jabbour, Elias
    Jain, Nitin
    Cortes, Jorge E.
    Estrov, Zeev
    Borthakur, Gautam
    Dong, Xiao Q.
    Kumar, Veeral J.
    Kantarjian, Hagop M.
    BLOOD, 2013, 122 (21)
  • [6] Patterns of total cost for patients (pts) with active treatment (Tx) of myelodysplastic syndromes (MDS).
    Smith, B. Douglas
    Dezern, Amy Elizabeth
    Binder, Gary
    Rizvi, Syed
    Corvino, Frank A.
    Arikian, Steven R.
    Surinach, Andy
    Lee, Jianyi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Risk factors in myelodysplastic syndromes (MDS): A single centre retrospective study
    Improta, S.
    Villa, M. R.
    Gagliardi, A.
    Della Cioppa, P.
    Lucania, A.
    Izzo, G. Nitrato
    Mastrullo, L.
    LEUKEMIA RESEARCH, 2013, 37 : S77 - S78
  • [8] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Iannella, E.
    Levi, A.
    Natalino, F.
    Alimena, G.
    LEUKEMIA RESEARCH, 2007, 31 : S107 - S107
  • [9] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Napoleone, L.
    Vozella, F.
    Levi, A.
    Natalino, E.
    Alimena, G.
    LEUKEMIA RESEARCH, 2008, 32 (10) : 1605 - 1607
  • [10] DIAGNOSIS AND CLINICAL CHARACTERISTICS OF MYELODYSPLASTIC SYNDROMES (MDS)
    KRIEGER, O
    LUTZ, D
    NOWOTNY, H
    HANAK, H
    BLUT, 1983, 47 (03): : 171 - 171
12345